Vol 31 (2021)

Supplement 1: BTK inhibitors approved in Canada for CLL: Strategies for adverse event management

Table of Contents

Articles

Nicole Dunse, Irene Hibbert, Sarah Doucette, Anna Christofides
PDF
1-11
Nicole Dunse, Irene Hibbert, Sarah Doucette, Anna Christofides
PDF
1-13